Efficacy and prognosis of chronic myeloid leukemia treated with imatinib mesylate in a Chinese population-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and prognosis of chronic myeloid leukemia treated with imatinib mesylate in a Chinese population

Published:2009-04-07 Issue:4 Volume:89 Page:445-451
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Zhao Yanmin,Liu Lizhen,Wang Yingjia,Wu Gongqiang,Lai Xiaoyu,Cao Weijie,Luo Yi,Tan Yamin,Shi Jimin,Xie Wanzhuo,Ye Xiujin,Cai Zhen,Lin Maofang,Huang He

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-009-0292-7.pdf

Reference21 articles.

1. Nash I. Chronic myeloid leukemia. N Engl J Med. 1999;341:765. doi: 10.1056/NEJM199909023411016 .

2. Kantarjian H, Sawyers C, Hochhaus A, et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med. 2002;346:645–52. doi: 10.1056/NEJMoa011573 .

3. Druker BJ, Guilhot F, O’Brien SG, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006;355:2408–17. doi: 10.1056/NEJMoa062867 .

4. Aziz Z, Iqbal J, Akram M, et al. Treatment of chronic myeloid leukemia in the imatinib era: perspective from a developing country. Cancer. 2007;109:1138–45. doi: 10.1002/cncr.22498 .

5. Rajappa S, Varadpande L, Paul T, et al. Imatinib mesylate in early chronic phase chronic myeloid leukemia: experience from a developing country. Leuk Lymphoma. 2008;49:554–8. doi: 10.1080/10428190701824585 .

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced-intensity allogeneic hematopoietic stem cell transplantation combined with imatinib has comparable event-free survival and overall survival to long-term imatinib treatment in young patients with chronic myeloid leukemia;Annals of Hematology;2017-06-17

2. Overcoming therapy failure in elderly patients with chronic myeloid leukemia;International Journal of Hematologic Oncology;2014-10

3. Clinical efficacy and safety of imatinib in the management of Ph+ chronic myeloid or acute lymphoblastic leukemia in Chinese patients;OncoTargets and Therapy;2014-03

4. Inhibitory effects of imatinib mesylate on human epidermal melanocytes;Clinical and Experimental Dermatology;2014-01-31

5. Report of chronic myeloid leukemia in chronic phase from Ashirwad Hematology Centre, Mumbai, 2002-2009;Indian Journal of Medical and Paediatric Oncology;2013-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3